BioMarin Pharmaceuticals
BMRN
BMRN
316 hedge funds and large institutions have $10.7B invested in BioMarin Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 110 increasing their positions, 123 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
316
Holders Change
-5
Holders Change %
-1.56%
% of All Funds
9.18%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.26%
New
35
Increased
110
Reduced
123
Closed
35
Calls
$86.2M
Puts
$34M
Net Calls
+$52.2M
Net Calls Change
+$12M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$908M |
| 2 |
O
2
OppenheimerFunds
New York
|
$132M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$86.7M |
| 4 |
4
Jennison Associates
New York
|
$430M |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$48.8M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
2
Norges Bank
Oslo,
Norway
|
$80.6M |
| 3 |
3
Neuberger Berman Group
New York
|
$38.6M |
| 4 |
4
Millennium Management
New York
|
$49.6M |
| 5 |
JCP
5
Jabre Capital Partners
Geneva,
Switzerland
|
$4.98M |
